Home » Newsletters » BioWorld

BioWorld

July 21, 2003

View Archived Issues

Vicuron Grosses $83.1M Through Public Offering Of Common Stock

Vicuron Pharmaceuticals Inc. priced a public offering of stock that raised $83.1 million in gross proceeds. (BioWorld Today) Read More

Medarex Raises $100M Via Notes Sale, Adds To Financing Flurry

Human Chromosome 7 Sequenced, Reveals New Data On Elfin Facies Of Childhood Congenital Syndrome

Isotechnika Completes $15M Funding With U.S. Investors

Bionaut Advancing Programs Following Series A Financing

Other News To Note

Appointments And Advancements

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...